EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
EyePoint, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$0.44−2.55 (-85.28%)
Close on Oct 19, 2026
- Market cap
- $38.08K
- P/E (TTM)
- –
- Dividend yield
- –
EyePoint, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $1.35M | $1.35M | $1.60M | $2.07M | $2.15M | $3.22M | $3.16M | $3.14M | $3.29M | $7.50M | $14.23M | $23.34M | 48.3% | -37.4% |
| License and Collaboration Agreements [Member] | $948.00K | $5.77M | $16.73M | $27.12M | $36.53M | $38.98M | $38.50M | $40.94M | $45.51M | $41.33M | $30.80M | $17.97M | 34.0% | -97.4% |
| Royalty Income [Member] | $493.00K | $493.00K | $13.04M | $13.15M | $13.21M | $13.84M | $1.61M | $1.64M | $1.59M | $1.20M | $989.00K | $1.21M | 17.7% | -96.3% |
| YUTIQ [Member] | – | – | – | – | – | $3.10M | $3.10M | $3.30M | $3.40M | $7.60M | $14.20M | $22.53M | – | – |
By region
From the segment and revenue-disaggregation notes of EyePoint's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.